Verseon Corporation Directorate Change (3411O)
29 Janvier 2019 - 8:00AM
UK Regulatory
TIDMVSN
RNS Number : 3411O
Verseon Corporation
29 January 2019
January 29, 2019
Verseon Corporation
("Verseon" or the "Company")
Directorate change
Fremont, Calif.--Verseon Corporation (AIM:VSN), a
technology-based pharmaceutical company, announces that Xavier
Rolet, on account of his recent executive appointment, will be
stepping down from his role as a non-executive director on February
23, 2019 in order to avoid any potential conflicts with Verseon and
its subsidiaries' businesses.
"We thank Xavier for his contribution and wish him every success
in his new role," said Adityo Prakash, CEO of Verseon.
About Verseon
Verseon Corporation (www.verseon.com, AIM: VSN) is developing
disruptive life-science technology to advance global health. The
clinical-stage company is using its proprietary, computational drug
discovery platform paired with a comprehensive in-house chemistry
and biology workflow to build a growing drug development pipeline.
Through its wholly owned subsidiary BlockRules Ltd., Verseon is
also pioneering blockchain technology for regulated securities.
-Ends-
For further information, please contact
Verseon Corporation www.verseon.com
+1 (510) 225
Sebastian Wykeham / Tina Schlafly 9000
Arden Partners (NOMAD and Joint Broker)
+44 (0) 20
Ruari McGirr / Ciaran Walsh 7614 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Phil Davies 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737
Simon Vane Percy 821 890
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAMMGZMMLNGLZG
(END) Dow Jones Newswires
January 29, 2019 02:00 ET (07:00 GMT)
Verseon (LSE:VSN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Verseon (LSE:VSN)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024